Fennec Pharmaceuticals (FENC) Enterprise Value Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -38.12% |
| Sep 30, 2025 | 45.57% |
| Jun 30, 2025 | 56.55% |
| Mar 31, 2025 | 55.70% |
| Dec 31, 2024 | -100.72% |
| Sep 30, 2024 | -225.19% |
| Jun 30, 2024 | -187.83% |
| Mar 31, 2024 | -285.74% |
| Dec 31, 2023 | 44.19% |
| Sep 30, 2023 | 58.33% |
| Jun 30, 2023 | -0.29% |
| Mar 31, 2023 | 27.33% |
| Dec 31, 2022 | -12.67% |
| Sep 30, 2022 | -22.26% |
| Jun 30, 2022 | 45.35% |
| Mar 31, 2022 | 31.74% |
| Dec 31, 2021 | 30.46% |
| Sep 30, 2021 | 26.63% |
| Jun 30, 2021 | 29.53% |
| Mar 31, 2021 | -170.18% |
| Dec 31, 2020 | -122.30% |
| Sep 30, 2020 | -117.62% |
| Jun 30, 2020 | -183.73% |
| Mar 31, 2020 | 51.06% |
| Dec 31, 2019 | 40.08% |
| Sep 30, 2019 | 37.86% |
| Jun 30, 2019 | 46.76% |
| Mar 31, 2019 | 24.28% |
| Dec 31, 2018 | 19.39% |
| Sep 30, 2018 | -153.14% |
| Jun 30, 2018 | -150.59% |
| Mar 31, 2018 | -721.87% |
| Dec 31, 2017 | -619.82% |
| Sep 30, 2017 | -113.53% |
| Jun 30, 2017 | -101.38% |
| Mar 31, 2017 | -496.51% |
| Dec 31, 2016 | -316.77% |
| Sep 30, 2016 | -232.14% |
| Jun 30, 2016 | -174.06% |
| Mar 31, 2016 | 71.56% |
| Dec 31, 2015 | 59.17% |
| Sep 30, 2015 | -130.35% |
| Jun 30, 2015 | -82.66% |
| Mar 31, 2015 | -43.20% |
| Dec 31, 2014 | -38.73% |
| Sep 30, 2014 | -10.22% |
| Jun 30, 2014 | -0.79% |
| Mar 31, 2014 | 29.43% |
| Dec 31, 2013 | 27.79% |
| Sep 30, 2013 | 81.19% |
| Jun 30, 2013 | 71.92% |
| Mar 31, 2013 | 59.82% |
| Dec 31, 2012 | 56.52% |
| Sep 30, 2012 | 53.68% |
| Jun 30, 2012 | 47.34% |
| Mar 31, 2012 | 6.05% |
| Dec 31, 2011 | 10.93% |
| Sep 30, 2011 | 6.48% |
| Jun 30, 2011 | 4.78% |